These results suggested that β-hydroxybutyrate played a key role in inhibiting the proliferation and migration of HCC cells by decreasing insulin production, which provided a new theoretical basis for applying the ketogenic diet in HCC treatment. This evidence concerns the gene INS and hepatocellular carcinoma.